Baha Arafah is an Endocrinology/Metabolic physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 78 publications with 4,989 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Provider last certified this registry record 13 Jan 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year20252 payments
- Corcept TherapeuticsProgram year20243 payments
- Abbott LaboratoriesProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
57.3%l-Thyroxine41%Levothyroxine Sodium77%Synthroid23%Part D≥104 patientsThyroid Hormone Synthesis Inhibitor6.5%Methimazole100%Part D≥19 patients+ 4 more classes in this area
Sensory organs
17.8%Corticosteroid17.8%Hydrocortisone88%Dexamethasone12%Part D<11 patientsNervous system
8.9%Ergot Derivative7.9%Cabergoline100%Part D≥21 patientsOther antiepileptics1%Levetiracetam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1985–2006 per NIH RePORTER. The latest:
- IMPACT OF HYDRATION STATUS ON INTERPRETATION OF TESTS TO ASSESS ADRENAL FUNCTION
Case Western Reserve University
FY2006$9,347M01RR000080 - HORMONE CONCENTRATIONS TO ASSESS ADRENAL FUNCTION IN CRITICALLY ILL PATIENTS
Case Western Reserve University
FY2006$549M01RR000080 - HORMONE CONCENTRATIONS TO ASSESS ADRENAL FUNCTION IN CRITICALLY ILL PATIENTS
Case Western Reserve University
FY2005$9,525M01RR000080
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Pharmacokinetic Data
The Journal of Clinical Endocrinology & Metabolism
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Sophia Sundararajan, MD
University Hospitals of Cleveland
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”